Ovarian CancerInfo Center
The US Food and Drug Administration (FDA) has approved a new use for the cancer medication Avastin (bevacizumab), according to biotechnology company Genentech.
Gene mutations associated with higher rates of breast and ovarian cancer may pose a serious risk to Ashkenazi Jewish (AJ) women, even those without a family history of cancer. This prompted a call for more genetic cancer screening.
Customizing treatments based on a patient’s genetics has led to more effective cancer treatments. Now, researchers have reported using ovarian cancer tumor types to predict how much one medication might benefit patients.
Ovarian cancer is the second most common cancer of the female reproductive organs. It's common for this cancer to return after initial treatment, but two therapies used together may help fight this cancer.
Women who know they have certain BRCA gene mutations may consider surgery to remove their breasts or ovaries to lower their risk of developing deadly cancers. But there may be other less aggressive options that can reduce their risk.
Bisphosphonates are a class of medications commonly used to prevent bone loss and osteoporosis. Now, it seems these medications might have an additional benefit: protection against certain cancers.
Parents may consider their age when having kids in terms of their own health and vitality as the children grow. But could parental age actually affect the future health of the children, too?
Scientists continue to search for ways to reduce cancer risk, and a leading authority on the subject released a new report shining light on one possible culprit.
Many young women today don’t worry too much about how old they will be when they have children. But for women with the gene for breast cancer, waiting to decide might have dire consequences.
Ovarian cancer is one of the most dangerous cancers of women's reproductive systems. However, a simple over-the-counter medication regimen may aid in preventing this cancer.